Our missions: serving patients, healthcare professionals and public health
Updated on
Prevent cancer onset
We design prevention campaigns to provide information on the onset of cancers and risk factors, and to promote the adoption of healthy behaviours.
Screen more
We help arrange and simplify organised screening programmes, and we carry out information campaigns to encourage French people to participate. We also prepare the screening of the future.
Ensure the same quality care throughout the country
We define the authorisation and accreditation criteria for healthcare institutions and professionals involved in cancer care to ensure that all our fellow citizens benefit from the same quality and safety of care.
Account for all patient needs
Supportive care, right of non-disclosure, job retention: we support all the stakeholders to allow every patient to have a normal life.
Produce and disseminate state-of-the-art guidelines for professionals
We draft guidelines with top experts in the field of cancer care organisation and pathways (multidisciplinary consultative meetings, diagnosis delivery processes, supportive oncological care, etc.), on therapeutic strategies, medicines and their adverse effects.
The aim is to provide all healthcare professionals with the state of the art in these topics.
Structure and fund research
We are tasked with implementing, funding and coordinating research and development initiatives in cancer care. We designate cancer research entities and organisations, meeting quality criteria, in consultation with the relevant public research organisations. We aim to develop excellence-based fundamental research and accelerate the transfer of findings for the benefit of patients.
Every year, we organize a dozen competitive calls for proposals and follow up the selected and funded proposals, representing almost 170 projects per year.
Anticipate therapeutic innovations
To stay ahead of upcoming developments, we have implemented a Horizon Scanning process that helps us identify high-impact innovations that may arise within a two-year period. We work with all agencies to anticipate their impact. We are also involved in preventing tensions by identifying at-risk medicines and drivers for action.
Strengthen international cooperation
This is now key to solving the most complex scientific questions.
In 2023, we set up “G7 cancer”, a coordination partnership including the leading countries in the fight against cancer. A consensus has been reached on four work topics: international data strategy, focused on paediatric cancers, poor prognosis cancers, inequalities, and prevention.
Broaden our knowledge on cancers, cancer onset, risk factors and patient outcomes
We develop epidemiological cancer observation via monitoring tools, studies, data collection and analysis. We also participate in the evaluation of the healthcare system, care and health pathways.
We have developed the Cancer Data Platform, a unique data warehouse in Europe compiling, under optimum security and confidentiality conditions, health data from various sources.
